ORIGINAL PAPER
Following the requirements of Breast Cancer Centre-bettering
outcomes of the treatment of the patients with a breast cancer
1
Institute of Health Sciences, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Head of the Institute: Edyta Suliga
2
Breast Cancer Unit, Holycross Cancer Centre, Kielce, Poland
Head of the Unit: Piotr Kędzierawski
3
Epidemiology and Cancer Control Department, Holycross Cancer Centre, Kielce, Poland
Head of the Department: Paweł Macek
Submission date: 2020-04-23
Acceptance date: 2020-07-17
Publication date: 2020-09-30
Medical Studies 2020;36(3):167-171
KEYWORDS
TOPICS
ABSTRACT
Introduction:
On 20 April 2015 the Breast Cancer Unit of Holycross Cancer Centre (HCC) in Kielce was granted with the certificate of the Senologic International Society (SIS), confirming the completion of quality criteria in diagnostics and therapy of patients with breast cancer (BC). In 2014 HCC strove to diagnose and treat patients with breast cancer following the commendations of the SIS.
Aim:
In this paper we provide the actualised outcomes of treatment after a 5-year observation.
Material and methods:
In 2014 a total of 409 women were qualified to radical treatment of invasive cancer in Holycross Cancer Centre. The median time of observation was 60 months. The probability of disease-free survival and overall survival was estimated by the Kaplan-Meier method.
Results:
Five-year disease-free survival (DFS) and overall survival (OS) for an entire group was 94% and 90%, respectively. DFS for women from pre-screening, screening, and post-screening age groups were 90%, 93%, and 89% and OS 89%, 90%, and 79%, respectively; DFS in patients with stage I, II, III, and IV was 98%, 95%, 76%, and 20%, respectively and OS 97%, 91%, 70%, and 20%, respectively.
Conclusions:
We believe that proper coordination and cooperation between specialists who are engaged in the process of diagnostics and treatment of women with breast cancer is an important factor leading to improved outcomes of treatment.
On 20 April 2015 the Breast Cancer Unit of Holycross Cancer Centre (HCC) in Kielce was granted with the certificate of the Senologic International Society (SIS), confirming the completion of quality criteria in diagnostics and therapy of patients with breast cancer (BC). In 2014 HCC strove to diagnose and treat patients with breast cancer following the commendations of the SIS.
Aim:
In this paper we provide the actualised outcomes of treatment after a 5-year observation.
Material and methods:
In 2014 a total of 409 women were qualified to radical treatment of invasive cancer in Holycross Cancer Centre. The median time of observation was 60 months. The probability of disease-free survival and overall survival was estimated by the Kaplan-Meier method.
Results:
Five-year disease-free survival (DFS) and overall survival (OS) for an entire group was 94% and 90%, respectively. DFS for women from pre-screening, screening, and post-screening age groups were 90%, 93%, and 89% and OS 89%, 90%, and 79%, respectively; DFS in patients with stage I, II, III, and IV was 98%, 95%, 76%, and 20%, respectively and OS 97%, 91%, 70%, and 20%, respectively.
Conclusions:
We believe that proper coordination and cooperation between specialists who are engaged in the process of diagnostics and treatment of women with breast cancer is an important factor leading to improved outcomes of treatment.
REFERENCES (6)
1.
Wilson ARM, Marotti L, Bianchi S, Biganzoli L, Claassen S, Decker T, Frigerio A, Goldhirsch A, Gustafsson EG, Mansel RE, Orecchia R, Ponti A, Poortmans P, Regitnig P, Rosselli Del Turco M, Rutgers EJT, van Asperen C, Wells CA, Wengström Y, Cataliotti L, EUSOMA (European Society of Breast Cancer Specialists). The requirements of a specialist Breast Centre. Eur J Cancer 2013; 49: 3579-3587.
3.
Kędzierawski P, Ciepiela I, Florek A, Bocian A, Macek P, Howorus M, Góźdź S. Long-term results of combined treatment patients with early breast cancer after conserving therapy. Medical Studies 2016; 32: 164-169.
4.
Kędzierawski P, Bocian A, Ciepiela I, Kołacińska A, Macek P, Góźdź S. Treatment outcomes of 213 breast cancer patients after sentinel lymph node biopsy – single center experience. Arch Med Sci Civil Dis 2017; 2: e130-e134.
5.
Bielska-Lasota M, Krzyżak M, Kwiatkowska K, Bogusz J, Maślach D, Wysocki MJ. Differences in treatment outcomes in selected cancers in Poland compared to other European countries in 2005-2009, based on CONCORD 2 study. Nowotwory J Oncol 2012; 66: 202-211.
6.
Cardoso F, Kyriakides S, Ohno S, Penault-Llorca P, Poortmans P, Rubio IT, Zackrisson S, Senkus E, ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30: 1194-1220.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
